← Back to Search

UR Caregiver group for Caregiver Burden

N/A
Recruiting
Led By Thomas Hadjistavropoulos, PhD
Research Sponsored by University of Regina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the pss-10 will be administered immediately after the 8-week period and at a 4-week follow-up period
Awards & highlights

Study Summary

This trial is testing a new app that aims to help caregivers of people with dementia manage their stress. Caregivers often experience a lot of stress, which can impact their mental health.

Who is the study for?
This trial is for unpaid caregivers, like family members, who are the primary carers for someone with dementia. They must own a smartphone or tablet but cannot already be using an app to manage caregiver stress.Check my eligibility
What is being tested?
The study tests a new app designed to help caregivers of people with dementia manage their stress. It will evaluate how effective the app is in providing strategies to alleviate the mental burden of caregiving.See study design
What are the potential side effects?
Since this trial involves using an app, there aren't typical medical side effects; however, users may experience frustration if they find it difficult to use or if technical issues arise.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the pss-10 will be administered immediately after the 8-week period and at a 4-week follow-up period
This trial's timeline: 3 weeks for screening, Varies for treatment, and the pss-10 will be administered immediately after the 8-week period and at a 4-week follow-up period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from after the 8-week period in the BSFC-S total scores at a 4-week follow-up
Change from after the 8-week period in the GAD-7 total scores at a 4-week follow-up
Change from after the 8-week period in the PHQ-9 total scores at a 4-week follow-up
+9 more
Secondary outcome measures
Change from after the 8-week period in the Brief-COPE subscale scores at a 4-week follow-up
Change from after the 8-week period in the CSES-8 total scores at a 4-week follow-up
Change from after the 8-week period in the MSPSS total scores at a 4-week follow-up
+6 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: UR Caregiver groupExperimental Treatment1 Intervention
Participants will be asked to use the UR Caregiver app daily (e.g., at least 15 minutes/day) for 8 weeks and complete and practice one module per week. On the eighth week, participants will be asked to review one of the past modules of their choice.
Group II: Active controlActive Control1 Intervention
Participants will be asked to use the app daily (e.g., at least 15 minutes/day) for an 8-week period.
Group III: Non-app using controlActive Control1 Intervention
Participants in this group will not be using any apps in the study.

Find a Location

Who is running the clinical trial?

University of ReginaLead Sponsor
48 Previous Clinical Trials
8,316 Total Patients Enrolled
1 Trials studying Caregiver Burden
175 Patients Enrolled for Caregiver Burden
Thomas Hadjistavropoulos, PhDPrincipal InvestigatorUniversity of Regina
1 Previous Clinical Trials
175 Total Patients Enrolled
1 Trials studying Caregiver Burden
175 Patients Enrolled for Caregiver Burden

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new patients currently being enrolled in this ongoing medical study?

"I apologize for the confusion. According to clinicaltrials.gov, this specific study is no longer actively seeking patients. It was initially posted on January 8th, 2024 and was last updated on February 1st, 2024. However, there are currently 431 other ongoing studies that are actively recruiting participants at this time."

Answered by AI
~133 spots leftby Jan 2025